Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats.

Milia AF, Manetti M, Generini S, Polidori L, Benelli G, Cinelli M, Messerini L, Ibba-Manneschi L, Matucci-Cerinic M.

J Cell Mol Med. 2009 Jan;13(1):164-76. doi: 10.1111/j.1582-4934.2008.00310.x. Epub 2008 Mar 19.

2.

Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α.

Milia AF, Ibba-Manneschi L, Manetti M, Benelli G, Generini S, Messerini L, Matucci-Cerinic M.

J Cell Mol Med. 2011 Feb;15(2):270-9. doi: 10.1111/j.1582-4934.2009.00984.x.

3.

Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.

Bertrand V, Quéré S, Guimbaud R, Sogni P, Chauvelot-Moachon L, Tulliez M, Lamarque D, Charreire J, Giroud JP, Couturier D, Chaussade S, Breban M.

Eur Cytokine Netw. 1998 Jun;9(2):161-70.

4.

Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment.

Veltkamp C, Anstaett M, Wahl K, Möller S, Gangl S, Bachmann O, Hardtke-Wolenski M, Länger F, Stremmel W, Manns MP, Schulze-Osthoff K, Bantel H.

Gut. 2011 Oct;60(10):1345-53. doi: 10.1136/gut.2010.217117. Epub 2011 Apr 1.

PMID:
21459928
5.

Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats.

Glatigny S, Fert I, Blaton MA, Lories RJ, Araujo LM, Chiocchia G, Breban M.

Arthritis Rheum. 2012 Jan;64(1):110-20. doi: 10.1002/art.33321.

6.

Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.

Peterson RL, Wang L, Albert L, Keith JC Jr, Dorner AJ.

Lab Invest. 1998 Dec;78(12):1503-12.

PMID:
9881950
7.

Increased tissue protein synthesis during spontaneous inflammatory bowel disease in HLA-B27 rats.

El Yousfi M, Breuillé D, Papet I, Blum S, André M, Mosoni L, Denis P, Buffière C, Obled C.

Clin Sci (Lond). 2003 Oct;105(4):437-46.

PMID:
12793856
8.

Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven.

Rauner M, Thiele S, Fert I, Araujo LM, Layh-Schmitt G, Colbert RA, Hofbauer C, Bernhardt R, Bürki A, Schwiedrzik J, Zysset PK, Pietschmann P, Taurog JD, Breban M, Hofbauer LC.

Bone. 2015 Jun;75:183-91. doi: 10.1016/j.bone.2015.02.024. Epub 2015 Mar 3.

PMID:
25746795
9.

Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.

Atreya R, Zimmer M, Bartsch B, Waldner MJ, Atreya I, Neumann H, Hildner K, Hoffman A, Kiesslich R, Rink AD, Rau TT, Rose-John S, Kessler H, Schmidt J, Neurath MF.

Gastroenterology. 2011 Dec;141(6):2026-38. doi: 10.1053/j.gastro.2011.08.032. Epub 2011 Aug 27.

PMID:
21875498
10.

Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats.

Rodríguez-Cabezas ME, Gálvez J, Camuesco D, Lorente MD, Concha A, Martinez-Augustin O, Redondo L, Zarzuelo A.

Clin Nutr. 2003 Oct;22(5):463-71.

PMID:
14512034
11.

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats.

Marroquin Belaunzaran O, Kleber S, Schauer S, Hausmann M, Nicholls F, Van den Broek M, Payeli S, Ciurea A, Milling S, Stenner F, Shaw J, Kollnberger S, Bowness P, Petrausch U, Renner C.

PLoS One. 2015 Jun 30;10(6):e0130811. doi: 10.1371/journal.pone.0130811. eCollection 2015.

12.

Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats.

Koleva PT, Valcheva RS, Sun X, Gänzle MG, Dieleman LA.

Br J Nutr. 2012 Nov 14;108(9):1633-43. doi: 10.1017/S0007114511007203. Epub 2012 Jan 16.

PMID:
22243836
13.

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.

Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, Breban M, McMichael AJ, Bowness P.

J Immunol. 2004 Aug 1;173(3):1699-710.

14.

Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.

Alavi K, Schwartz MZ, Palazzo JP, Prasad R.

J Pediatr Surg. 2000 Jun;35(6):847-51.

PMID:
10873024
15.

Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability.

Dhaenens M, Fert I, Glatigny S, Haerinck S, Poulain C, Donnadieu E, Hacquard-Bouder C, André C, Elewaut D, Deforce D, Breban M.

Arthritis Rheum. 2009 Sep;60(9):2622-32. doi: 10.1002/art.24780.

16.

Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease.

Kim YS, Son M, Ko JI, Cho H, Yoo M, Kim WB, Song IS, Kim CY.

Arch Pharm Res. 1999 Aug;22(4):354-60.

PMID:
10489873
17.

HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides.

Milia AF, Ibba-Manneschi L, Manetti M, Benelli G, Messerini L, Matucci-Cerinic M.

Ann N Y Acad Sci. 2009 Sep;1173:570-4. doi: 10.1111/j.1749-6632.2009.04757.x. Review.

PMID:
19758201
18.

HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats.

DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA.

Arthritis Rheum. 2009 Sep;60(9):2633-43. doi: 10.1002/art.24763.

19.

Intestinal Metabolites Are Profoundly Altered in the Context of HLA-B27 Expression and Functionally Modulate Disease in a Rat Model of Spondyloarthritis.

Asquith M, Davin S, Stauffer P, Michell C, Janowitz C, Lin P, Ensign-Lewis J, Kinchen JM, Koop DR, Rosenbaum JT.

Arthritis Rheumatol. 2017 Oct;69(10):1984-1995. doi: 10.1002/art.40183. Epub 2017 Aug 31.

PMID:
28622455
20.

TNFα causes thrombin-dependent vagal neuron apoptosis in inflammatory bowel disease.

Fritze D, Zhang W, Li JY, Chai B, Mulholland MW.

J Gastrointest Surg. 2014 Sep;18(9):1632-41. doi: 10.1007/s11605-014-2573-6. Epub 2014 Jun 25.

Supplemental Content

Support Center